Serge Bodart1, Bill Byrom2, Mabel Crescioni3, Sonya Eremenco3, Emuella Flood4. 1. 1 Bracket Global, Montreal, Quebec, Canada. 2. 2 CRF Health, London, Greater London, United Kingdom. 3. 3 Critical Path Institute, Tucson, AZ, USA. 4. 4 ICON Clinical Research, Gaithersburg, MD, USA.
Abstract
BACKGROUND: Understanding the perceived burden of clinical trial participation is an important element of patient-centric trial design and conduct. METHODS: We report the results of a study to gain preliminary insights into the perceived burden associated with patient-reported outcome (PRO) data collection among a sample (n = 61) of volunteers from the general population including people with various health conditions resulting in chronic pain. RESULTS: Participants identified morning completion as more burdensome than completion of PRO measures in the evening. Weekly completion was perceived as less burdensome than daily, and twice-a-day more burdensome than once-a-day. CONCLUSION: Our results, while not generalizable in isolation, provide a valuable starting point to understand the complex construct of subject burden. This preliminary work is intended to be a catalyst for more in-depth research to better understand and predict burden and acceptable burden thresholds in clinical trials. Understanding subject burden is a vital component of human subject research that will be valuable in helping to inform future clinical trial designs.
BACKGROUND: Understanding the perceived burden of clinical trial participation is an important element of patient-centric trial design and conduct. METHODS: We report the results of a study to gain preliminary insights into the perceived burden associated with patient-reported outcome (PRO) data collection among a sample (n = 61) of volunteers from the general population including people with various health conditions resulting in chronic pain. RESULTS:Participants identified morning completion as more burdensome than completion of PRO measures in the evening. Weekly completion was perceived as less burdensome than daily, and twice-a-day more burdensome than once-a-day. CONCLUSION: Our results, while not generalizable in isolation, provide a valuable starting point to understand the complex construct of subject burden. This preliminary work is intended to be a catalyst for more in-depth research to better understand and predict burden and acceptable burden thresholds in clinical trials. Understanding subject burden is a vital component of human subject research that will be valuable in helping to inform future clinical trial designs.
Authors: David J Weiss; Chun Wang; Andrea L Cheville; Jeffrey R Basford; Joseph DeWeese Journal: Arch Phys Med Rehabil Date: 2021-10-01 Impact factor: 4.060
Authors: Grisselle DeFrank; Sarina Singh; Katrina F Mateo; Laura Harrison; Alyson Rosenthal; Allison Gorman; May May Leung Journal: Pilot Feasibility Stud Date: 2019-09-05
Authors: Jérémie Mikhail; Léonie Hofstetter; Pierre Côté; Andrea C Tricco; Isabelle Pagé; Cesar A Hincapié Journal: BMJ Open Date: 2022-06-27 Impact factor: 3.006